A Study on the Efficacy of 24 Weeks of Sofosbuvir, Daclatasvir with Ribaravin in the Treatment of Chronic Hepatitis C Patients with Cirrhosis, Genotype 1 and 3. - Nitali Arun; Anand Dev; V. K. Singh (Asian Journal of Medical Research, 2019)